| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Sep―24 |
Real-life practice of Kelleni’s protocol in treatment and post exposure prophylaxis of SARS-CoV-2 HV.1 and JN.1 subvariants |
Mina Thabet Kelleni |
| 2 |
[GO] |
2025―Sep―24 |
Pre-hospital proton pump inhibitor use and clinical outcomes in hospitalized COVID-19 patients: A retrospective case-control study |
Harinivaas Shanmugavel Geetha, Sushmita Prabhu, Mithil Gowda Suresh, George M Abraham, Akshaya Sekar, Safia Mohamed, Abinesh Sekar, Juniali Hatwal, Aalam Sohal, Akash Batta |
| 3 |
[GO] |
2025―Jun―23 |
Genomic and demographic characterization of SARS-CoV-2 infections within early Omicron cluster, Western Sri Lanka |
Nipuni Arachchige, Ramesha Dharmasiri, Achini Weerathunga, Shehan Senanayake, Nadeeka Janage, Rohitha Muthugala |
| 4 |
[GO] |
2025―Jun―23 |
Alpha to JN.1 variants: SARS-CoV-2 genomic analysis unfolding its various lineages/sublineages evolved in Chhattisgarh, India from 2020 to 2024 |
Pushpendra Singh, Ruchi Khare, Kuldeep Sharma, Anudita Bhargava, Sanjay Singh Negi |
| 5 |
[GO] |
2025―Jun―23 |
Examining rhabdomyolysis-related acute kidney injury in COVID-19 patients and its comparison to other acute kidney injury types |
Liyan Ajit D Souza, Abdulqadir J Nashwan |
| 6 |
[GO] |
2025―Jun―23 |
COVID-19 management in patients with comorbid conditions |
Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic, Stephanie Prakash, Vyshnavy Balendra, Amine Lehachi, Abu Fahad Abbasi, Nafees Haider, Amos Abioye, Verner N Orish, Afolabi Antonio, Olanrewaju Badaru, Rajashree Pandit, Ricardo Izurieta |
| 7 |
[GO] |
2025―Jun―23 |
Risk of COVID-19 infection among frontline healthcare workers during the COVID-19 pandemic |
Kundavaram Paul Prabhakar Abhilash, Mathew Varghese Nellimootil, Binila Chacko, Darpanarayan Hazra, Victor Coelho, John Emmanuel Jesudasan, Karthik Gunasekaran, Lovely Thomas, More Atul Ramchandra, Jonathan Melchizedek, Henah Meshack Gunaraj, Mahesh Moorthy, John Victor Peter |
| 8 |
[GO] |
2024―Nov―27 |
Revisiting dexamethasone dosage in COVID-19 management |
Abhishet Varama |
| 9 |
[GO] |
2024―Nov―26 |
Convergence of COVID-19 and recurrent stroke: In-hospital mortality risks explored |
Basavraj S Nagoba, Shree V Dhotre, Ajay M Gavkare, Sachin S Mumbre, Pradnya S Dhotre |
| 10 |
[GO] |
2024―Nov―26 |
Unveiling the impact: COVID-19's influence on bacterial resistance in the Kingdom of Bahrain |
Nermin K Saeed, Safiya K Almusawi, Noor A Albalooshi, Mohammed Al-Beltagi |
| 11 |
[GO] |
2024―Nov―26 |
Rhabdomyolysis-related acute kidney injury in COVID-19: A critical concern |
Md Safiullah Sarker |
| 12 |
[GO] |
2024―Nov―26 |
Dexamethasone in coronavirus disease 2019 care: Dosage and utilization insights |
Laiba Shamim, Imshaal Musharaf, Abdulqadir J Nashwan |
| 13 |
[GO] |
2024―Nov―26 |
Serological surveillance for SARS-CoV-2 antibodies among students, faculty and staff within a large university system during the pandemic |
Marcos G Pinheiro, Gabriela G O Alves, Maria Eduarda R Conde, Sofia L Costa, Regina C S Sant’Anna, Isa M F Antunes, Mônica C Carneiro, Fabio S Ronzei, Julia C Scaffo, Felipe R Pinheiro, Lialyz S Andre, Helvecio C Povoa, Valéria T Baltar, Fabíola Giordani, Eduarda S Hemerly, Gisele C Alexandre, Karla C de Paula, Márcio Watanabe, Antonio Claudio L da Nóbrega, Jackeline Christiane P Lobato, Fabio Aguiar-Alves |
| 14 |
[GO] |
2024―Okt―18 |
Impact of vitamin D on COVID-19 and other viral diseases |
Basavraj S Nagoba, Ajay M Gavkare, Abhijit S Rayate, Neeta Nanaware, Sachin Bhavthankar |
| 15 |
[GO] |
2024―Okt―18 |
Understanding rhabdomyolysis induced acute kidney injury in patients with COVID-19 |
Alexander Ikanović, Karan Varshney |
| 16 |
[GO] |
2024―Okt―18 |
COVID-19 in pregnancy: Perinatal outcomes and complications |
Karolina Akinosoglou, Georgios Schinas, Evangelia Papageorgiou, Theodoros Karampitsakos, Vasiliki Dimakopoulou, Eleni Polyzou, Argyrios Tzouvelekis, Markos Marangos, Despoina Papageorgiou, Nikolaos Spernovasilis, George Adonakis |
| 17 |
[GO] |
2024―Okt―18 |
Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey |
Eyiuche D Ezigbo, Seyi S Enitan, Esther N Adejumo, Abiodun E Durosinmi, Richard Y Akele, Michael O Dada, Grace E Itodo, Abah M Idoko, Okeoghene M Edafetanure-Ibeh, Edwin N Okafor, Adedeji A Abdulsalam, Oyekan I Oyedoyin, Polit U Yelpoji, Ogunwola O Opeyemi, Ogbuji S Nmesomachi, Adesola O Oyekale, Chisom B Onyeji |
| 18 |
[GO] |
2024―Okt―18 |
Role of viruses in periodontitis: An extensive review of herpesviruses, human immunodeficiency virus, coronavirus-19, papillomavirus and hepatitis viruses |
Mohammed Khalid Mahmood, Mohammed Taib Fatih, Handren Ameer Kurda, Nwsiba Khalid Mahmood, Farman Uthman Shareef, Hemin Faraidun, Herve Tassery, Delphine Tardivo, Romain Lan, Zana Fuad Noori, Balen Hamid Qadir, Arman Dlshad Hassan |
| 19 |
[GO] |
2024―Aug―29 |
Rhabdomyolysis-related acute kidney injury in patients with COVID-19 |
Ahmet Murt, Mehmet Riza Altiparmak |
| 20 |
[GO] |
2024―Aug―29 |
Recurrent stroke admissions with vs without COVID-19 and associated in-hospital mortality: A United States nationwide analysis, 2020 |
Rupak Desai, Sai Priyanka Mellacheruvu, Sai Anusha Akella, Adil Sarvar Mohammed, Mushfequa Hussain, Abdul Aziz Mohammed, Pakhal Saketha, Praveena Sunkara, Jyotsna Gummadi, Paritharsh Ghantasala |
| 21 |
[GO] |
2024―Aug―29 |
Role of vitamin D in COVID-19 and other viral infections |
Muhammet Mesut Nezir Engin, Öner Özdemir |
| 22 |
[GO] |
2024―Aug―29 |
Dosage and utilization of dexamethasone in the management of COVID-19: A critical review |
Imran Sethi, Asim Shaikh, Musa Sethi, Hira Khalid Chohan, Sheraz Younus, Syed A Khan, Salim Surani |
| 23 |
[GO] |
2024―Jun―24 |
Harnessing immunity: Immunomodulatory therapies in COVID-19 |
Tsvetelina Velikova, Hristo Valkov, Anita Aleksandrova, Monika Peshevska-Sekulovska, Metodija Sekulovski, Russka Shumnalieva |
| 24 |
[GO] |
2024―Jun―24 |
Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic |
Jing-Wen Liu, Yue-Yue Li, Ming-Ke Wang, Ji-Shun Yang |
| 25 |
[GO] |
2024―Jun―24 |
Impact of COVID-19 pandemic on routine childhood vaccinations |
Shi-Rong Lv, Ming-Ke Wang, Xue-Lu Yu, Xin-Yue Li, Ji-Shun Yang |
| 26 |
[GO] |
2024―Jun―24 |
Paradigm shift in transfusion practices during early COVID-19 pandemic: A single center retrospective study |
Sumukh Arun Kumar, Sushmita Prabhu, Ankushi Sanghvi, Maya Gogtay, Mithil Gowda Suresh, Harshit Khosla, Yuvaraj Singh, Ajay Kumar Mishra, Susan George |
| 27 |
[GO] |
2024―Jun―24 |
Lab results of COVID-19 patients: Omicron vs delta variants |
Dana Avraham, Amir Herman, Gal Shaham, Arkady Shklyar, Elina Sulim, Maria Oulianski |
| 28 |
[GO] |
2024―Jun―24 |
Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality? |
Brady Madioko Makanzu, Jean-Robert Makulo, Madone Ndona Mandina, Dimosi Roger Wumba, Murielle Mashi Longokolo, Hippolyte Situakibanza, Ossam Odio, Donat Sonzi Mangala, Constantin Mihigo Bashengezi, Benjamin Kabwe Mwilambwe, Gilbert Kabanda Kurhenga, Benjamin Longo-Mbenza, Roger Mwimba Mbungu |
| 29 |
[GO] |
2024―Jun―24 |
Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2 |
Emily E Zona, Mina L Gibes, Asha S Jain, Jeannina A Smith, Jacqueline M Garonzik-Wang, Didier A Mandelbrot, Sandesh Parajuli |
| 30 |
[GO] |
2024―Mrz―11 |
Country-based modelling of COVID-19 case fatality rate: A multiple regression analysis |
Soodeh Sagheb, Ali Gholamrezanezhad, Elizabeth Pavlovic, Mohsen Karami, Mina Fakhrzadegan |
| 31 |
[GO] |
2024―Mrz―11 |
Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations: A propensity-matched analysis of the United States |
Abdullah Sohail, Hassam Ali, Pratik Patel, Subanandhini Subramanium, Dushyant Singh Dahiya, Amir H Sohail, Manesh Kumar Gangwani, Sanjaya K Satapathy |
| 32 |
[GO] |
2024―Mrz―11 |
Efficacy and safety of bamlanivimab in patients with COVID-19: A systematic review and meta-analysis |
Behnam Amani, Lida Khodavirdilou, Kourosh Rajabkhah, Vida Kardan Moghaddam, Arash Akbarzadeh, Bahman Amani |
| 33 |
[GO] |
2023―Dez―25 |
COVID-19 frequency and clinical course in children with asthma |
Muhammet Cihat Özata, Ümmügülsüm Dikici, Öner Özdemir |
| 34 |
[GO] |
2023―Dez―25 |
Routine pediatric vaccinations during the COVID-19 pandemic: A review of the global impact |
Jennifer Locke, Aleksandra Marinkovic, Kareem Hamdy, Vyshnavy Balendra, Adekunle Sanyaolu |
| 35 |
[GO] |
2023―Dez―25 |
Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease? |
Harinivaas Shanmugavel Geetha, Sushmita Prabhu, Abinesh Sekar, Maya Gogtay, Yuvaraj Singh, Ajay K Mishra, George M Abraham, Suzanne Martin |
| 36 |
[GO] |
2023―Sep―19 |
Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States |
Faisal Inayat, Hassam Ali, Pratik Patel, Rubaid Dhillon, Arslan Afzal, Attiq Ur Rehman, Muhammad Sohaib Afzal, Laraib Zulfiqar, Gul Nawaz, Muhammad Hassan Naeem Goraya, Subanandhini Subramanium, Saurabh Agrawal, Sanjaya K Satapathy |
| 37 |
[GO] |
2023―Jun―21 |
Pediatric multisystem inflammatory syndrome associated with COVID-19: Insights in pathogenesis and clinical management |
Marcel Silva Luz, Fabian Fellipe Bueno Lemos, Samuel Luca Rocha Pinheiro, Hanna Santos Marques, Luís Guilherme de Oliveira Silva, Mariana Santos Calmon, Karolaine da Costa Evangelista, Fabrício Freire de Melo |
| 38 |
[GO] |
2023―Jun―21 |
Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation |
A H M Nurun Nabi, Akio Ebihara, Hossain Uddin Shekhar |
| 39 |
[GO] |
2023―Jun―21 |
Etiopathogenic theories about long COVID |
Luis Del Carpio-Orantes |
| 40 |
[GO] |
2023―Mrz―21 |
Immune-mediated liver injury following COVID-19 vaccination |
Georgios Schinas, Eleni Polyzou, Vasiliki Dimakopoulou, Stamatia Tsoupra, Charalambos Gogos, Karolina Akinosoglou |
| 41 |
[GO] |
2023―Mrz―21 |
The impact of COVID-19 on liver injury in various age |
Amin Sadeghi Dousari, Seyed Soheil Hosseininasab, Fatemeh Sadeghi Dousari, Masoumeh Fuladvandi, Naghmeh Satarzadeh |
| 42 |
[GO] |
2023―Mrz―21 |
Intestinal barrier dysfunction as a key driver of severe COVID-19 |
Efthymios P Tsounis, Christos Triantos, Christos Konstantakis, Markos Marangos, Stelios F Assimakopoulos |
| 43 |
[GO] |
2023―Mrz―21 |
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2 |
Ali Osman Gulmez, Sonay Aydin |
| 44 |
[GO] |
2023―Mrz―21 |
Demographic and risk characteristics of healthcare workers infected with SARS-CoV-2 from two tertiary care hospitals in the United Arab Emirates |
Prashant Nasa, Payal Modi, Gladys Setubal, Aswini Puspha, Surjya Upadhyay, Syed Habib Talal |
| 45 |
[GO] |
2023―Mrz―21 |
Effect of SARS-CoV-2 infection on the liver |
Adekunle Sanyaolu, Aleksandra Marinkovic, Abu Fahad Abbasi, Stephanie Prakash, Risha Patidar, Priyank Desai, Martina Williams, Abdul Jan, Kareem Hamdy, Rachael Solomon, Vyshnavy Balendra, Maaz Ansari, Omar Shazley, Nasar Khan, Rochelle Annan, Yashika Dixon, Chuku Okorie, Afolabi Antonio |
| 46 |
[GO] |
2023―Jan―17 |
Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment |
Ruo-Bing Qi, Zheng-Hao Wu |
| 47 |
[GO] |
2023―Jan―17 |
COVID-19 in patients with pre-existing chronic liver disease - predictors of outcomes |
Dinesh Walia, Anoop Saraya, Deepak Gunjan |
| 48 |
[GO] |
2023―Jan―17 |
Commentary on COVID-19-induced liver injury in various age and risk groups |
Öner Özdemir, Hacer Efnan Melek Arsoy |
| 49 |
[GO] |
2023―Jan―17 |
COVID-19-related liver injury: Focus on genetic and drug-induced perspectives |
Deepak Parchwani, Amit D Sonagra, Sagar Dholariya, Anita Motiani, Ragini Singh |
| 50 |
[GO] |
2023―Jan―17 |
Severe acute respiratory syndrome coronavirus 2 may cause liver injury via Na+/H+ exchanger |
Medine Cumhur Cure, Erkan Cure |
| 51 |
[GO] |
2022―Nov―23 |
Cholestatic liver injury: A rare but fatal complication during and after COVID-19 infection |
Wachira Wongtanasarasin |
| 52 |
[GO] |
2022―Nov―23 |
Effects of COVID-19 on children with autism |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Rawan Alhawamdeh, Samara Qaraghuli |
| 53 |
[GO] |
2022―Nov―23 |
Potential risk of liver injury in epileptic patients during COVID-19 pandemic |
Nasim Tabrizi, Athena Sharifi-Razavi |
| 54 |
[GO] |
2022―Nov―23 |
Intensive care unit adaptations in the COVID-19 pandemic: Lessons learned |
Anwar Khedr, David Rokser, Jeanine Borge, Hannah Rushing, Greta Zoesch, Wade Johnson, Han-Yin Wang, April Lanz, Brian N Bartlett, Jessica Poehler, Salim Surani, Syed A Khan |
| 55 |
[GO] |
2022―Nov―23 |
Clinical characteristics of COVID-19 patients who underwent tracheostomy and its effect on outcome: A retrospective observational study |
Yudhyavir Singh, Kapil Dev Soni, Abhishek Singh, Nikita Choudhary, Fahina Perveen, Richa Aggarwal, Nishant Patel, Shailendra Kumar, Anjan Trikha |
| 56 |
[GO] |
2022―Nov―23 |
COVID-19-induced liver injury in adult patients: A brief overview |
Martina Grando, Massimiliano Balbi, Marco Zeppieri |
| 57 |
[GO] |
2022―Nov―23 |
Musculoskeletal complications in long COVID-19: A systematic review |
Raktim Swarnakar, Shoibam Jenifa, Sanjay Wadhwa |
| 58 |
[GO] |
2022―Nov―23 |
Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control |
Niya Narayanan, Dukhabandhu Naik, Jayaprakash Sahoo, Sadishkumar Kamalanathan |
| 59 |
[GO] |
2022―Nov―23 |
Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective |
Farina M Hanif, Zain Majid, Shoaib Ahmed, Nasir H Luck, Muhammed Mubarak |
| 60 |
[GO] |
2022―Nov―23 |
Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned? |
Jalil Roohani, Masoud Keikha |
| 61 |
[GO] |
2022―Nov―23 |
Effect of the pandemic on rehabilitation healthcare services in India: Breaking barriers |
Raktim Swarnakar, Shiv Lal Yadav |
| 62 |
[GO] |
2022―Sep―24 |
Anatomophysiological relationships and clinical considerations of taste and smell loss in patients with COVID-19 |
Maria Fernanda Rossi Vigliar, Karina Torres Pomini, Daniela Vieira Buchaim, Rogerio Leone Buchaim |
| 63 |
[GO] |
2022―Sep―24 |
Acute kidney injury and electrolyte disorders in COVID-19 |
Gabriel Martins Nogueira, Noel Lucas Oliveira Rodrigues Silva, Ana Flávia Moura, Marcelo Augusto Duarte Silveira, José A Moura-Neto |
| 64 |
[GO] |
2022―Sep―24 |
COVID-19 and hemolysis, elevated liver enzymes and thrombocytopenia syndrome - association or causation? |
Prashant Nasa, Deven Juneja, Ravi Jain, Ruchi Nasa |
| 65 |
[GO] |
2022―Sep―24 |
Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan |
Mousa Ahmad Qatawneh, Moath Altarawneh, Ruba Alhazaimeh, Mais Jazazi, Omaiema Jarrah, Alaa Shorman, Laila Alsadah, Maher Mustafa |
| 66 |
[GO] |
2022―Sep―24 |
Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis |
Ivan Cancarevic, Mahmoud Nassar, Ahmed Daoud, Hatem Ali, Nso Nso, Angelica Sanchez, Avish Parikh, Asma Ul Hosna, Bhavana Devanabanda, Nazakat Ahmed, Karim M Soliman |
| 67 |
[GO] |
2022―Sep―24 |
Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview |
Deven Juneja, Anish Gupta, Sahil Kataria, Omender Singh |
| 68 |
[GO] |
2022―Sep―24 |
Possible agent for COVID-19 treatment: Rifampicin |
Ozlem Celik Aydin, Sonay Aydın, Sureyya Barun |
| 69 |
[GO] |
2022―Sep―24 |
Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic |
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Hristiana Batselova, Radostina Alexandrova, Tsvetelina Velikova |
| 70 |
[GO] |
2022―Sep―24 |
Association of COVID-19 with hepatic metabolic dysfunction |
Ramesh Kumar, Vijay Kumar, Rahul Arya, Utpal Anand, Rajeev Nayan Priyadarshi |
| 71 |
[GO] |
2022―Sep―24 |
Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019 |
Raid M Al-Ani |
| 72 |
[GO] |
2022―Sep―24 |
Effect of age on computed tomography findings: Specificity and sensitivity in coronavirus disease 2019 infection |
Erdal Karavas, Edhem Unver, Sonay Aydın, Gonul Seven Yalcin, Erdem Fatihoglu, Ufuk Kuyrukluyildiz, Yusuf Kemal Arslan, Mustafa Yazici |
| 73 |
[GO] |
2022―Sep―24 |
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2 |
Anjani Muthyala, Sandeep Sasidharan, Kevin John John, Amos Lal, Ajay K Mishra |
| 74 |
[GO] |
2022―Sep―24 |
SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure |
Bipradas Roy, Sadia Afrin Runa |
| 75 |
[GO] |
2022―Jul―22 |
Air leaks in COVID-19 |
Deven Juneja, Sahil Kataria, Omender Singh |
| 76 |
[GO] |
2022―Jul―22 |
COVID-19 pandemic effects on the distribution of healthcare services in India: A systematic review |
Nirav Nimavat, Mohammad Mehedi Hasan, Sundip Charmode, Gowthamm Mandala, Ghanshyam R Parmar, Ranvir Bhangu, Israr Khan, Shruti Singh, Amit Agrawal, Ashish Shah, Vishi Sachdeva |
| 77 |
[GO] |
2022―Jul―22 |
“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor |
Vasiliki Tsigkou, Gerasimos Siasos, Evangelos Oikonomou, Evanthia Bletsa, Manolis Vavuranakis, Dimitris Tousoulis |
| 78 |
[GO] |
2022―Jul―22 |
COVID-19 presenting with persistent hiccup and myocardial infarction in a peritoneal dialysis patient: A case report |
Dimitra Bacharaki, Panagiotis Giannakopoulos, Konstantinos Markakis, Christos Papas, Aikaterini Theodorou, Vasiliki Zoi, Georgios Tsivgoulis, Sophia Lionaki |
| 79 |
[GO] |
2022―Jul―22 |
COVID-19 vaccination and myocarditis: A review of current literature |
Kartik Dhaduk, Jagjit Khosla, Muzna Hussain, Vrunda Mangaroliya, Shaylika Chauhan, Kumar Ashish, Rahul Gupta, Suman Pal |
| 80 |
[GO] |
2022―Jul―22 |
Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy |
Tarun Sahu, Henu Kumar Verma, Bhaskar Lvks |
| 81 |
[GO] |
2022―Mai―20 |
Impact of COVID-19 on mental health and emotional well-being of older adults |
Letha Mullamkuzhy Joseph |
| 82 |
[GO] |
2022―Mai―20 |
Educational, psychosocial, and clinical impact of SARS-CoV-2 (COVID-19) pandemic on medical students in the United States |
Veronica Frank, Anjali Doshi, Natalie L Demirjian, Brandon K K Fields, Catherine Song, Xiaomeng Lei, Sravanthi Reddy, Bhushan Desai, Drayton C Harvey, Steven Cen, Ali Gholamrezanezhad |
| 83 |
[GO] |
2022―Mai―20 |
Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade |
Mohaddeseh Bahmani, Rojin Chegini, Elham Ghanbari, Elham Sheykhsaran, Parisa Shiri Aghbash, Hamed Ebrahimzadeh Leylabadlo, Ehsan Moradian, Amir Masoud Kazemzadeh Houjaghan, Hossein Bannazadeh Baghi |
| 84 |
[GO] |
2022―Mai―20 |
Omicron variant and change of electrostatic interactions between receptor binding domain of severe acute respiratory syndrome coronavirus 2 with the angiotensin-converting enzyme 2 receptor |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 85 |
[GO] |
2022―Mai―20 |
SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape |
Adekunle Sanyaolu, Aleksandra Marinkovic, Stephanie Prakash, Nafees Haider, Martina Williams, Chuku Okorie, Olanrewaju Badaru, Stella Smith |
| 86 |
[GO] |
2022―Mrz―22 |
Too hard to die: Exercise training mediates specific and immediate SARS-CoV-2 protection |
Konstantinos I Papadopoulos, Warachaya Sutheesophon, Tar-Choon Aw |
| 87 |
[GO] |
2022―Mrz―22 |
Novel appearance of hyperglycemia/diabetes, associated with COVID-19 |
Ioannis Ilias |
| 88 |
[GO] |
2022―Mrz―22 |
Rifampicin for COVID-19 |
George D Panayiotakopoulos, Dimitrios T Papadimitriou |
| 89 |
[GO] |
2022―Mrz―22 |
Bacterial and fungal co-infection is a major barrier in COVID-19 patients: A specific management and therapeutic strategy is required |
Tarun Sahu, Henu Kumar Verma, Lakkakula V K S Bhaskar |
| 90 |
[GO] |
2022―Mrz―22 |
Therapeutic potential of N-acetyl cysteine during COVID-19 epoch |
Ajita Kapur, Munish Sharma, Geetanjali Sageena |
| 91 |
[GO] |
2022―Jan―15 |
Role of vitamin D deficiency and comorbidities in COVID-19 |
Gabriela Gama Freire Alberca, Ricardo Wesley Alberca |
| 92 |
[GO] |
2022―Jan―15 |
Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19 |
Josef Finsterer, Fulvio A Scorza, Carla A Scorza, Ana C Fiorini |
| 93 |
[GO] |
2022―Jan―15 |
Rethinking hospital psychiatry in Italy in light of COVID-19 experience |
Marco P Piccinelli, Paola Bortolaso, Greg D Wilkinson |
| 94 |
[GO] |
2022―Jan―15 |
Heart failure in COVID-19 patients: Critical care experience |
Kevin John John, Ajay K Mishra, Chidambaram Ramasamy, Anu A George, Vijairam Selvaraj, Amos Lal |
| 95 |
[GO] |
2022―Jan―15 |
COVID-19: A pluralistic and integrated approach for efficient management of the pandemic |
Nouhoum Bouare, Daouda Kassim Minta, Abdoulaye Dabo, Christiane Gerard |
| 96 |
[GO] |
2022―Jan―15 |
Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation |
Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Rajesh Jeewon, Jian-Dong Huang, Siva Sundara Kumar Durairajan |
| 97 |
[GO] |
2021―Nov―22 |
Effects of COVID-19 in lymphoid malignancies |
Öner Özdemir |
| 98 |
[GO] |
2021―Nov―22 |
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective |
Sheila Gato, Ana Lucena-Valera, Rocío Muñoz-Hernández, José Manuel Sousa, Manuel Romero-Gómez, Javier Ampuero |
| 99 |
[GO] |
2021―Nov―22 |
Evaluation of an asymptomatic COVID-19 patient post-surgery with chest radiography: A surgeon’s dilemma |
Gaurav Govil, Lavindra Tomar, Pawan Dhawan |
| 100 |
[GO] |
2021―Nov―22 |
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review |
Valentina Bonuomo, Isacco Ferrarini, Michele Dell'Eva, Eugenio Sbisà, Mauro Krampera, Carlo Visco |
| 101 |
[GO] |
2021―Sep―16 |
COVID-19 in dialysis units: A comprehensive review |
Gabriel Martins Nogueira, Moisés Santana Oliveira, Ana Flávia Moura, Constança Margarida Sampaio Cruz, José A Moura-Neto |
| 102 |
[GO] |
2021―Sep―16 |
New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis |
Dhan Bahadur Shrestha, Pravash Budhathoki, Sumit Raut, Sugat Adhikari, Prinska Ghimire, Sabin Thapaliya, Ali A Rabaan, Bibodh Jung Karki |
| 103 |
[GO] |
2021―Sep―16 |
Scientific evidence in the COVID-19 treatment: A comprehensive review |
Gorane Iturricastillo, Elena Ávalos Pérez-Urría, Felipe Couñago, Pedro Landete |
| 104 |
[GO] |
2021―Sep―16 |
Ambisense polarity of genome RNA of orthomyxoviruses and coronaviruses |
Oleg Zhirnov |
| 105 |
[GO] |
2021―Jul―20 |
Hypotheses and facts for genetic factors related to severe COVID-19 |
Stanislav Vasilev Kotsev, Dimitrina Miteva, Stanislava Krayselska, Martina Shopova, Maria Pishmisheva-Peleva, Spaska Angelova Stanilova, Tsvetelina Velikova |
| 106 |
[GO] |
2021―Jul―20 |
Current systematic reviews and meta-analyses of COVID-19 |
Mahmoud Nassar, Nso Nso, Mostafa Alfishawy, Anastasia Novikov, Salim Yaghi, Luis Medina, Bahtiyar Toz, Sofia Lakhdar, Zarwa Idrees, Yungmin Kim, Dawa Ongyal Gurung, Raheel S Siddiqui, David Zheng, Mariam Agladze, Vikram Sumbly, Jasmine Sandhu, Francisco Cuevas Castillo, Nadya Chowdhury, Ravali Kondaveeti, Sakil Bhuiyan, Laura Guzman Perez, Riki Ranat, Carlos Gonzalez, Harangad Bhangoo, John Williams, Alaa Eldin Osman, Joyce Kong, Jonathan Ariyaratnam, Mahmoud Mohamed, Ismail Omran, Mariely Lopez, Akwe Nyabera, Ian Landry, Saba Iqbal, Anoosh Zafar Gondal, Sameen Hassan, Ahmed Daoud, Bahaaeldin Baraka, Theo Trandafirescu, Vincent Rizzo |
| 107 |
[GO] |
2021―Jul―20 |
Exploiting epidemiological data to understand the epidemiology and factors that influence COVID-19 pandemic in Libya |
Abdusalam S Mahmoud, Abdunaser S Dayhum, Abdunnabi A Rayes, Badereddin B Annajar, Ibrahim M Eldaghayes |
| 108 |
[GO] |
2021―Jul―20 |
Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain |
Nermin Kamal Saeed, Safaa Al-Khawaja, Jameela Alsalman, Safiya Almusawi, Noor Ahmed Albalooshi, Mohammed Al-Biltagi |
| 109 |
[GO] |
2021―Mai―18 |
Impact of COVID-19 in patients with lymphoid malignancies |
John Charles Riches |
| 110 |
[GO] |
2021―Mai―18 |
Chest radiography requirements for patients with asymptomatic COVID-19 undergoing coronary artery bypass surgery: Three case reports |
Amr Salah Omar, Bassam Shoman, Suraj Sudarsanan, Yasser Shouman |
| 111 |
[GO] |
2021―Mai―18 |
Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach |
Dimitrios T Papadimitriou, Alexandros K Vassaras, Michael F Holick |
| 112 |
[GO] |
2021―Mai―18 |
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients |
Wattana Leowattana |
| 113 |
[GO] |
2021―Mrz―16 |
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 |
Asimina Dominari, Donald Hathaway III, Abdulhusein Kapasi, Trissa Paul, Sarabjot Singh Makkar, Valeria Castaneda, Sirisha Gara, Bishnu Mohan Singh, Kuchalambal Agadi, Maliha Butt, Varadha Retnakumar, Spandana Chittajallu, Rahima Taugir, Muhammad Khawar Sana, Manish KC, Sarah Razzack, Niala Moallem, Alina Alvarez, Michael Talalaev |
| 114 |
[GO] |
2021―Mrz―16 |
Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza |
Masafumi Seki |
| 115 |
[GO] |
2021―Mrz―16 |
Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review |
Anna Maria Spera |
| 116 |
[GO] |
2021―Jan―21 |
Emerging therapeutics in the management of COVID-19 |
Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh, Akif Kichloo |
| 117 |
[GO] |
2020―Dez―10 |
Reinfection risk of novel coronavirus (CoVID-19): A systematic review of current evidence |
SeyedAhmad SeyedAlinaghi, Shahram Oliaei, Shaghayegh Kianzad, Amir Masoud Afsahi, Mehrzad MohsseniPour, Alireza Barzegary, Pegah Mirzapour, Farzane Behnezhad, Tayebeh Noori, Esmaeil Mehraeen, Omid Dadras, Fabricio Voltarelli, Jean-Marc Sabatier |
| 118 |
[GO] |
2020―Okt―25 |
Management strategies in a thoracic surgery ward during COVID-19 pandemic: Experience from West China Hospital |
Lin Lin, Ling-Li Niu, E Zheng, Yong Yuan, Ning Ning, Mei Yang |
| 119 |
[GO] |
2020―Sep―24 |
Chinese medical students’ interest in COVID-19 pandemic |
Nan-Ze Yu, Zhi-Jin Li, Yu-Ming Chong, Yuan Xu, Jun-Ping Fan, Yang Yang, Yue Teng, Yu-Wei Zhang, Wen-Chao Zhang, Ming-Zi Zhang, Jiu-Zuo Huang, Xiao-Jun Wang, Shu-Yang Zhang, Xiao Long |
| 120 |
[GO] |
2020―Sep―24 |
Current status of COVID-19 treatment: An opinion review |
Sveva Di Franco, Aniello Alfieri, Stephen Petrou, Giovanni Damiani, Maria Beatrice Passavanti, Maria Caterina Pace, Sebastiano Leone, Marco Fiore |
| 121 |
[GO] |
2020―Mai―22 |
Case of COVID-19 presenting with gastrointestinal symptoms |
Ravi Kant, Lakshya Chandra, Mc Anto Antony, Vipin Verma |
